Desipramine-induced	desipramine-induced	O	O
delirium	delirium	O	S_disease
at	at	O	O
"	"	O	O
subtherapeutic	subtherapeutic	O	O
"	"	O	O
concentrations	concentrations	O	O
:	:	O	O
a	a	O	O
case	case	O	O
report	report	O	O
.	.	O	O

An	an	O	O
elderly	elderly	O	O
patient	patient	O	O
treated	treated	O	O
with	with	O	O
low	low	O	O
dose	dose	O	O
Desipramine	desipramine	S_chemical	O
developed	developed	O	O
a	a	O	O
delirium	delirium	O	S_disease
while	while	O	O
her	her	O	O
plasma	plasma	O	O
level	level	O	O
was	was	O	O
in	in	O	O
the	the	O	O
"	"	O	O
subtherapeutic	subtherapeutic	O	O
"	"	O	O
range	range	O	O
.	.	O	O

Delirium	delirium	O	S_disease
,	,	O	O
which	which	O	O
may	may	O	O
be	be	O	O
induced	induced	O	O
by	by	O	O
tricyclic	tricyclic	O	O
drug	drug	O	O
therapy	therapy	O	O
in	in	O	O
the	the	O	O
elderly	elderly	O	O
,	,	O	O
can	can	O	O
be	be	O	O
caused	caused	O	O
by	by	O	O
tricyclics	tricyclics	O	O
with	with	O	O
low	low	O	O
anticholinergic	anticholinergic	O	O
potency	potency	O	O
.	.	O	O

Therapeutic	therapeutic	O	O
ranges	ranges	O	O
for	for	O	O
antidepressants	antidepressants	S_chemical	O
that	that	O	O
have	have	O	O
been	been	O	O
derived	derived	O	O
from	from	O	O
general	general	O	O
adult	adult	O	O
population	population	O	O
studies	studies	O	O
may	may	O	O
not	not	O	O
be	be	O	O
appropriate	appropriate	O	O
for	for	O	O
the	the	O	O
elderly	elderly	O	O
.	.	O	O

Further	further	O	O
studies	studies	O	O
of	of	O	O
specifically	specifically	O	O
elderly	elderly	O	O
patients	patients	O	O
are	are	O	O
now	now	O	O
required	required	O	O
to	to	O	O
establish	establish	O	O
safer	safer	O	O
and	and	O	O
more	more	O	O
appropriate	appropriate	O	O
guidelines	guidelines	O	O
for	for	O	O
drug	drug	O	O
therapy	therapy	O	O
.	.	O	O

